Executive Chair and Former Chief Executive Officer · CareDx, Inc. (CDNA)

Peter Maag

A named executive officer of CareDx in every fiscal year CompBrief holds from FY2017 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$6,400,015

Salary $488,700Stock awards $3,327,600

FY2019: $9,424,083

1st of 5 named executive officers at CareDx by FY2020 total.

5 named officers on file for CareDx, FY2020

Peter Maag’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 13 equity grants, each cited to its filing
  • CDNA’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CareDx’s whole pay program stands against its peers

  • CareDx’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CDNA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Peter Maag’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Peter Maag compensation by year

CareDx Summary Compensation Table · all 4 fiscal years held
In US dollars, as CareDx reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020
Salary$450,000$483,750$510,030$488,700
Bonus$0$0$0$0
Stock awards$306,900$2,728,322$6,673,480$3,327,600
Option awards$264,837$1,324,759$1,670,674$1,721,935
Non-equity incentive$378,000$693,000$568,339$860,220
Pension and deferred compensation$0$0$0$0
All other$1,560$1,560$1,560$1,560
Total$1,401,297$5,231,391$9,424,083$6,400,015

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CareDx, Inc. DEF 14A filed April 30, 2021, accession 0001217234-21-000079, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CareDx, Inc. filed document, accession 0001217234-21-000079. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

$1.4M
$5.2M
$9.4M
$6.4M
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU40,000$1,379,600—
RSU37,500$1,035,375—
RSU36,000$978,120—
RSU40,000$974,000—
RSU40,000$974,000—
RSU75,000$918,000—
RSU22,212$140,158—
RSU4,500$10,350—
Option1,250—$2.30
Option3,125—$2.80
Option9,375—$5.90
Option50,000—$27.17

Per the Outstanding Equity Awards at Fiscal Year-End table in CareDx, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 16 award rows shown.

Insider transactions since the last proxy

31 Form 4 lines since the FY2020 proxy (filed April 30, 2021)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-07-07Sale—10,000$18.58308,846
2025-06-17Sale10b5-110,000$19.24318,846
2025-06-13Grant or award—12,103$0.00328,846
2025-04-30Sale10b5-113,281$17.23316,743
2024-11-26Exercise or conversion10b5-15,000$12.24335,024
2024-11-26Sale10b5-15,000$25.00330,024
2024-11-26Exercise or conversion derivative10b5-15,000$0.001,250
2024-08-20Exercise or conversion—26,708$7.96365,576

The 8 most recent of 31 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

CareDx’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Peter Maag · this pageExecutive Chair and Former Chief Executive Officer$6,400,015
MBBS Reginald SeetoChief Executive Officer, President and Chief Business Officer$5,618,698
Michael BellFormer Chief Financial Officer (4)$3,443,952
Sasha KingChief Marketing Officer$1,541,104
Marcel KonradFormer Interim Chief Financial Officer$953,469

Board service

CareDx board · FY2022–FY2025
Director compensation in US dollars, as CareDx reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$52,747$224,995$0$0$277,742
FY2024$49,993$149,988$150,049—$350,030
FY2023$54,935$149,998$149,995—$354,928
FY2022$43,235$99,983$156,379—$299,597

Each year as the company reported it in CareDx's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: CareDx pays directors a $50,000 cash retainer and $225,000 in RSUs. As stated in CareDx's FY2025 proxy.

Committees

Nominating/Governance · Technology and Innovation

The full CareDx compensation record

free company brief

This page is one person within CareDx's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CareDx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Peter Maag's compensation dossier · One-time report. No refunds.